Literature DB >> 9581723

Predictors of restenosis after coronary stent implantation.

C Bauters1, E Hubert, A Prat, K Bougrimi, E Van Belle, E P McFadden, P Amouyel, J M Lablanche, M Bertrand.   

Abstract

OBJECTIVES: We sought to determine predictors of restenosis after coronary stenting (CS) in a consecutive series of patients.
BACKGROUND: Although stenting in highly selected patient groups reduces restenosis, the results of stenting in a heterogeneous patient group and the effects of clinical and procedural factors on stent restenosis are currently unclear.
METHODS: We analyzed the 6-month angiographic outcome of 500 lesions in 463 consecutive patients undergoing successful CS. Clinical, qualitative and quantitative angiographic variables were correlated with restenosis assessed as both a binary and a continuous variable.
RESULTS: Restenosis, defined as the presence of >50% diameter stenosis in the dilated segment, was present in 105 (26%) of the 405 lesions with angiographic follow-up. The mean late lumen loss during the follow-up period was 0.79+/-0.64 mm. Implantation of multiple stents (p < 0.0001) and a high acute gain (p < 0.0002) were independently associated with a higher late lumen loss. In contrast, the use of high inflation pressure (p < 0.02) and Palmaz-Schatz stents (p < 0.005) was independently associated with a lower late lumen loss. When restenosis was defined as a qualitative variable, implantation of multiple stents (p < 0.001), stenosis length (p < 0.01), small reference diameter (p < 0.02) and stent type other than Palmaz-Schatz (p < 0.01) were independent predictors of restenosis. None of the clinical variables tested was associated with restenosis.
CONCLUSIONS: Coronary stenting in an unselected patient group is associated with an acceptable restenosis rate. Although some risk factors were identified, the risk of restenosis was not related to most of the variables tested. This suggests that the superiority of CS over balloon angioplasty, in terms of restenosis, might also apply to subgroups of patients that were not included in the recent randomized studies.

Entities:  

Mesh:

Year:  1998        PMID: 9581723     DOI: 10.1016/s0735-1097(98)00076-x

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.

Authors:  Ralf Zahn; C W Hamm; S Schneider; U Zeymer; G Richardt; M Kelm; B Levenson; T Bonzel; U Tebbe; G Sabin; C A Nienaber; Thomas Pfannebecker; J Senges
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

Review 3.  A risk-benefit assessment of abciximab in angioplasty.

Authors:  N S Kleiman
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

4.  Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patients.

Authors:  R T van Domburg; D P Foley; P P de Jaegere; P de Feyter; M van den Brand; W van der Giessen; J Hamburger; P W Serruys
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

5.  Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries.

Authors:  C M Gross; J Krämer; O Weingärtner; F Uhlich; R Dietz; J Waigand
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

6.  Cost-effectiveness of intracoronary flow velocity measurements and myocardial perfusion scintigraphy for management of intermediate coronary lesions.

Authors:  S A J Chamuleau; M G W Dijkgraaf; B L F van Eck-Smit; J G P Tijssen; J J Piek
Journal:  Neth Heart J       Date:  2005-06       Impact factor: 2.380

7.  Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.

Authors:  S J Hong; M H Kim; T H Ahn; Y K Ahn; J H Bae; W J Shim; Y M Ro; D-S Lim
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

Review 8.  Small coronary vessel angioplasty: outcomes and technical considerations.

Authors:  Sudhir Rathore
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

9.  Reversible defects on myocardial perfusion imaging early after coronary stent implantation: a predictor of late restenosis.

Authors:  Dae-Weung Kim; Soon-Ah Park; Chang-Guhn Kim; Cheol Lee; Seok Kyu Oh; Jin-Won Jeong
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-13       Impact factor: 2.357

10.  Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: results from the prospective multi-center German Cypher Stent Registry.

Authors:  Christian Zellerhoff; Steffen Schneider; Jochen Senges; Thomas Pfannebecker; Christian Hamm; Ulrich Tebbe
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.